Taikang Asset
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Taikang Asset is an asset management firm.
Investor Profile
Taikang Asset has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Pharmaceutical, Biopharma.
Stage Focus
- Series C (50%)
- Series B (25%)
- Post Ipo Equity (25%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Biopharma
- Health Care
- Medical
- Electronics
- Manufacturing
- Retail
- Education
- Language Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
